Search

everythinglearnresearchcommunity

for

Search:↓

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

Alopecia areata severity and symptoms vary by race and ethnicity.

A new tool can analyze hair to detect changes due to hormones, genetics, and aging.

Media attention increased oral minoxidil prescriptions for English-preferring patients but not for Spanish-preferring patients.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Salvianolic Acid B helps hair grow by reducing cell stress and increasing blood flow to hair follicles.

Miliacin helps extend the hair growth phase in mice with hair loss.

Kinematic alignment in knee surgery often requires smaller femoral components than mechanical alignment.

Robotic surgery's benefits over traditional methods are unclear and need more research.

Liraglutide with metformin reduces body fat and improves blood sugar control better than metformin and inositol in women with prediabetes.

Different people with severe hair loss respond to baricitinib treatment at different times, with some showing improvement early, some gradually, and others later.

Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.

Microbial communities in Duku plant roots vary between wet and dry habitats, affecting plant health.

Menopause causes skin and hair to become drier and thinner, but hormone therapy can improve these conditions.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Including special area involvement helps identify more psoriasis patients who may need systemic treatment.

Platelet-rich plasma (PRP) may improve healing in chronic wounds and vitiligo and promote hair regrowth, but more research is needed.

Hair loss (androgenetic alopecia) mildly to moderately affects men's quality of life but not significantly their mental health.

Men with male pattern baldness have higher uric acid levels, which can decrease with finasteride treatment.

Different types of female pattern hair loss have unique characteristics and are associated with various health conditions.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

During the COVID-19 pandemic in China, skin conditions like eczema and warts increased among children, while respiratory-transmitted skin infections decreased, partly due to mask-wearing.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

Cepharanthine helps reduce cell aging caused by the cancer drug Doxorubicin by boosting cell cleanup processes.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

The COVID-19 pandemic led to fewer patient visits, more visits by older adults, an increase in cutaneous T-cell lymphoma cases, and a rise in noncosmetic procedures at a dermatology clinic.